UNVERIFIEDSingle SourceSTAT+: Compass says depression drug has long-lasting benefitsStat News|7/7/2026
UNVERIFIEDSingle SourceSTAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diverseStat News|7/6/2026
UNVERIFIEDSingle SourceSTAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learnedStat News|7/6/2026
UNVERIFIEDSingle SourceSTAT+: Roche drug sets new standard for KRAS-driven lung cancer Stat News|7/2/2026
UNVERIFIEDSingle SourceSTAT+: A former AI regulator, now in industry, says biopharma is reading FDA’s guidance wrongStat News|7/2/2026
UNVERIFIEDSingle SourceSTAT+: More signs that GLP-1s may help with peripheral artery diseaseStat News|7/1/2026
UNVERIFIEDSingle SourceSTAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patientsStat News|7/1/2026
UNVERIFIEDSingle SourceSTAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watchStat News|7/1/2026
UNVERIFIEDSingle SourceOpinion: What Ebola and Marburg are teaching us about the next pandemicStat News|7/1/2026
UNVERIFIEDSingle SourceSTAT+: AI company Anthropic announces it will begin developing drugs of its ownStat News|6/30/2026
UNVERIFIEDSingle SourceSTAT+: Anthropic releases Claude Science, a product aimed at researchers, the pharma industryStat News|6/30/2026